Journal article · 2026
Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors
Journal of Medicinal Chemistry, 69(21), 25361–25378 · Published 17 October 2026 · DOI 10.1021/acs.jmedchem.6c01265
In brief
“Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors” is a 2026 journal article by Tammy Ladduwahetty and 24 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 2.40
- References
- 35
- Authors
- 25
Abstract
Hematological toxicities have resulted in limiting the dose of first-generation PARP inhibitors, which have activity at both PARP1 and PARP2. With the advancement of selective PARP1 inhibitors to the clinic, we embarked on a program to identify novel PARP1 inhibitors that are suitable for the treatment of CNS malignancies. Central to our design was the… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ladduwahetty, T., Rahemtulla, B. F., Talbot, E. P. A., Bateman, J., Benson, N., 陈鹏源, Cockcroft, X. F., Feng, L., Gozalpour, E., Lin, K., Moroglu, M., Qin, Y., Raoshan, E., Ratnam, J., Shen, Y., Sollis, S., Tong, Z., Wang, T., Westwood, M., . . . Foote, K. M. (2026). Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors. Journal of Medicinal Chemistry, 69(21), 25361–25378. https://doi.org/10.1021/acs.jmedchem.6c01265
MLA 9
Ladduwahetty, Tammy, et al. “Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors.” Journal of Medicinal Chemistry, vol. 69, no. 21, 2026, pp. 25361–25378. https://doi.org/10.1021/acs.jmedchem.6c01265.
Chicago
Ladduwahetty, Tammy, Benjamin F. Rahemtulla, Eric P. A. Talbot, Joseph Bateman, Neil Benson, 陈鹏源, Xiaoling F. Cockcroft, et al. 2026. “Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors.” Journal of Medicinal Chemistry 69 (21): 25361–25378. https://doi.org/10.1021/acs.jmedchem.6c01265.
Harvard
Ladduwahetty, T. et al. (2026) ‘Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors’, Journal of Medicinal Chemistry, 69(21), pp. 25361–25378. doi:10.1021/acs.jmedchem.6c01265.
IEEE
T. Ladduwahetty et al., “Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors,” Journal of Medicinal Chemistry, vol. 69, no. 21, pp. 25361–25378, 2026, doi: 10.1021/acs.jmedchem.6c01265.
BibTeX
@article{ladduwahetty2026discovery,
title = {{Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors}},
author = {Ladduwahetty, Tammy and Rahemtulla, Benjamin F. and Talbot, Eric P. A. and Bateman, Joseph and Benson, Neil and 陈鹏源 and Cockcroft, Xiaoling F. and Feng, Li and Gozalpour, Elnaz and Lin, Kui and Moroglu, Mustafa and Qin, Yi and Raoshan, Emily and Ratnam, Joseline and Shen, Yang and Sollis, Steve and Tong, Zixuan and Wang, Tingzhong and Westwood, Marta and Xie, Yiming and Yeap, Siew Kuen and Rui, Yuan and Watt, Gillian F. and Taylor, Simon and Foote, Kevin M.},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {21},
pages = {25361--25378},
doi = {10.1021/acs.jmedchem.6c01265},
url = {https://doi.org/10.1021/acs.jmedchem.6c01265}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP-1 inhibitors
- oral bioavailability
- drug efflux
- hematologic toxicity
- CNS malignancies
- tumor growth inhibition
- pharmacokinetic-pharmacodynamic modeling
- once-daily dosing
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Ladduwahetty, T., Rahemtulla, B. F., Talbot, E. P. A., Bateman, J., Benson, N., 陈鹏源, Cockcroft, X. F., Feng, L., Gozalpour, E., Lin, K., Moroglu, M., Qin, Y., Raoshan, E., Ratnam, J., Shen, Y., Sollis, S., Tong, Z., Wang, T., Westwood, M., . . . Foote, K. M. (2026). Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors. Journal of Medicinal Chemistry, 69(21), 25361–25378. https://doi.org/10.1021/acs.jmedchem.6c01265
How many times has this paper been cited?
1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Tammy Ladduwahetty, Benjamin F. Rahemtulla, Eric P. A. Talbot, Joseph Bateman, Neil Benson, 陈鹏源, Xiaoling F. Cockcroft, Li Feng, Elnaz Gozalpour, Kui Lin, Mustafa Moroglu, Yi Qin and 13 more.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c01265, permanently at https://doi.org/10.1021/acs.jmedchem.6c01265. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.